Index of artpub/2023/301690/

Querol, Luis
An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy
2023
https://ddd.uab.cat/record/301690